Board members of the European Society of Gene and Cell Therapy
The ESGCT Board is composed of researchers and clinicians representing a broad range of European Countries. Board members are elected by nomination and vote at the Annual General Meeting which is usually held during the Annual Congress.
The President and Vice-President of the society are appointed for two years and the other members of the Board are appointed for three years. For full details of governance arrangements please see section 4 of the society constitution. If you would like to express an interest in becoming a Board member please don’t hesitate to contact office@esgct.eu for details of the nomination process.
Luigi Naldini
President
"Università Vita Salute San Raffaele" School of Medicine
San Raffaele Telethon Institute for Gene Therapy via Olgettina 58,
20132 Milano
Nathalie Cartier-Lacave
Vice-President
INSERM U745, Faculté de Pharmacie, 2,
avenue de l'Observatoire,
75006 Paris
Christof von Kalle Treasurer
Treasurer
National Center for Tumor Diseases (NCT) Heidelberg
Im Neuenheimer Feld 460
69120 Heidelberg
Len Seymour
General Secretary
Head of Cancer Research UK Gene Delivery Group,
University of Oxford,
Old Road Campus Research Building, Headington
OX3 7DQ Oxford
Alessandro Aiuti
"Università Vita Salute San Raffaele" School of Medicine
San Raffaele Telethon Institute for Gene Therapy via Olgettina 58,
20132 Milano
Robin Ali
Institute of Ophthalmology
University College London
Bath St
EC1V 9EL London
Hildegard Büning
Department I of Internal Medicine and
Center for Molecular Medicine Cologne (CMMC)
University of Cologne
Robert-Koch-Str. 21
50931 Cologne
Sarah Ferber
The Center for Regenerative Medicine, Stem Cells and Tissue Engineering
Sheba Medical Ctr.
52621 Tel-Hashomer
Hidde Haisma
Groningen Research Institute for Pharmacy,
Deusinglaan 1
9713AV Groningen
Zoltan Ivics
Division of Medical Biotechnology
Paul Ehrlich Institute
Paul Ehrlich Str. 51-59
63225 Langen